通过同时抑制病毒复制和炎症反应,通过印莫他辛对抗泛冠状病毒感染
Yining Wang1, Pengfei Li1, Lei Xu1,2
1Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.
iScience
|September 4, 2023
概括
印米他辛通过增强干扰素反应,对冠状病毒表现出广泛的抗病毒活性. 将其与现有的抗病毒药物或干扰素α结合起来,可以提高其有效性,为抗击病毒感染和炎症提供双重方法.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的冠状病毒感染引发高炎症,需要针对病毒和免疫反应的治疗.
- 现有的治疗策略往往侧重于病毒清除或炎症控制,强调了结合方法的必要性.
研究的目的:
- 确定有效对抗泛冠病毒的广泛抗病毒药物.
- 调查印米他辛作为病毒复制和炎症的双重抑制剂的潜力.
- 探索涉及印梅他辛的协同治疗组合.
主要方法:
- 对安全的人类抗病毒剂库的选,以确定泛冠状病毒抑制剂.
- 药物查试验用于识别干扰素反应的强化剂.
- 在人体细胞和呼吸道有机体模型的体外研究.
- 肺上皮细胞和巨细胞的共同培养系统.
主要成果:
- 在细胞和有机体模型中,印米他辛对多种冠状病毒表现出广泛的抗病毒活性.
- 通过增加STAT1酸化,印梅他辛增强了干扰素反应,作为一种强大的干扰素反应增强剂.
- 印梅他辛与FDA批准的口服抗病毒药物或干扰素α的联合治疗显示出协同作用的抗冠状病毒效应.
- 在共同培养系统中,印米他辛有效抑制了病毒复制和病毒诱导的炎症反应.
结论:
- 印米他辛被确定为一种强大的泛冠状病毒抑制剂,能够同时抑制病毒复制和病毒引发的炎症.
- 印米他辛的抗病毒机制与干扰素反应途径的激活有关.
- 印梅他辛具有显著的治疗潜力,可以通过与现有的口服抗病毒药物或干扰素α结合来进一步放大,用于治疗严重的冠状病毒感染.
相关概念视频
01:28Inflammatory Response
2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
01:38Inflammation
53.8K
Overview
53.8K
01:28Antimicrobial Effectiveness
44
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
44
01:29Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
01:22Methods of reducing fever
697
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
697